Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating lorcaserin in combination with XR-naltrexone for relapse prevention in opioid use disorder has completed…
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail [NA]
A completed randomized trial evaluating interim methadone and patient navigation initiated in jail for opioid use disorder; results posted i…
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: The Life STORRIED Study [NA]
The Life STORRIED Study (NCT03134092) sponsored by the University of Pennsylvania has completed enrollment and posted results as of August 1…
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075 [EARLY_Phase 1]
Early-phase trial update on a buprenorphine physician-pharmacist collaboration for opioid use disorder; completed with results posted in 202…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: The Influence of ANS-6637 on Midazolam Pharmacokinetics in Healthy Volunteers [Phase 1]
Phase 1 study evaluating how ANS-6637 affects midazolam pharmacokinetics in healthy volunteers; results completed and posted in 2020.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Evaluation of Long-term Buprenorphine Plasma Exposure
A completed clinical trial evaluating long-term buprenorphine plasma exposure in individuals with opioid-use disorder, with results posted i…
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: Opioid-free Anesthesia for Open Cardiac Surgery: A Prospective Randomized Controlled Trial [Phase 3]
A Phase 3 randomized trial evaluating opioid-free anesthesia for open cardiac surgery has completed.
-
FDA approval · 2020-07-17FDA Approved: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE — Original Application (Accord Healthcare, Inc)
FDA approves Accord Healthcare's generic combination product of buprenorphine hydrochloride and naloxone hydrochloride dihydrate for opioid …
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block [Phase 4]
Phase 4 trial comparing analgesic duration of dexmedetomidine versus dexamethasone as adjuncts to single-shot interscalene block; results po…
-
FDA approval · 2020-06-23FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for buprenorphine hydrochloride submitted by Par Health USA, LLC.
-
FDA approval · 2020-06-15FDA Approved: SUBLOCADE — Supplemental Application (Indivior Inc.)
The FDA approved Indivior's supplemental application for SUBLOCADE (buprenorphine), resulting in regulatory action on the product's labeling…
-
FDA approval · 2020-06-15FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approves Hikma Pharmaceuticals USA Inc.'s supplemental application for buprenorphine hydrochloride, enabling a generic product entry…
-
FDA approval · 2020-05-08FDA Approved: VIVITROL — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for VIVITROL (naltrexone) submitted by Alkermes, Inc., updating the product labeling.
-
FDA approval · 2020-05-05FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for methadone hydrochloride manufactured by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: Phase II Pharmacokinetics Study of CAM2038 [Phase 2]
Phase II pharmacokinetics study of CAM2038 completed with results posted.
-
FDA approval · 2020-04-17FDA Approved: BUPRENORPHINE AND NALOXONE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan's original application for a generic buprenorphine/naloxone product for the treatment of opioid use disorder.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Attention Training for Opioid-maintained Cocaine Users [Phase 4]
Phase 4 trial update on attention training for individuals maintained on opioids for cocaine addiction.
-
FDA approval · 2020-03-30FDA Approved: BUPRENORPHINE AND NALOXONE — Original Application (Rhodes Pharmaceuticals L.P.)
FDA approved the original application for a buprenorphine and naloxone combination product from Rhodes Pharmaceuticals L.P. for the treatmen…
-
CLINICAL_TRIALS withdrawal · 2020-03-24Clinical Trial Update: Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology [Phase 4]
A Phase 4 trial comparing buprenorphine alone versus buprenorphine with naloxone for maternal symptomatology in opioid-use disorder was with…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051
A completed clinical trial evaluating tau opioid use outcomes after discharge from detoxification and short-term residential programs affili…
-
FDA approval · 2020-03-16FDA Approved: METHADONE HYDROCHLORIDE — Original Application (VistaPharm, LLC)
FDA approves VistaPharm's methadone hydrochloride as a generic drug under an original ANDA; the product is intended for analgesic use and fo…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR [NA]
A completed clinical trial evaluating usability testing of clinical decision support for opioid use disorders within an electronic medical r…
-
FDA approval · 2020-03-02FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
The FDA approved a supplemental application for SUBOXONE (buprenorphine/naloxone) submitted by Indivior Inc. The update covers the approved …
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Discharge Opioid Education to Decrease Opioid Use After Cesarean [NA]
A completed clinical trial evaluating discharge opioid education to reduce opioid use after cesarean delivery.
-
FDA approval · 2020-02-04FDA Approved: SUBLOCADE — Supplemental Application (Indivior Inc.)
The FDA approved a supplemental application for SUBLOCADE (buprenorphine) from Indivior Inc., resulting in updated labeling.